中药药理与临床2024,Vol.40Issue(11) :67-71.

腰痛活血胶囊对强直性脊柱炎Th1/Th2型趋化因子的影响

Effects of Yaotong Huoxue(腰痛活血)Capsules on Th1/Th2 Chemokines in Ankylosing Spondylitis

葛瑶 黄传兵 万磊 汪元 谌曦 张皖东 范海霞 曹云祥 王桂珍 陈瑞莲 刘健
中药药理与临床2024,Vol.40Issue(11) :67-71.

腰痛活血胶囊对强直性脊柱炎Th1/Th2型趋化因子的影响

Effects of Yaotong Huoxue(腰痛活血)Capsules on Th1/Th2 Chemokines in Ankylosing Spondylitis

葛瑶 1黄传兵 1万磊 1汪元 1谌曦 1张皖东 1范海霞 1曹云祥 1王桂珍 1陈瑞莲 1刘健1
扫码查看

作者信息

  • 1. 安徽中医药大学第一附属医院,合肥 230031
  • 折叠

摘要

目的:观察并研究腰痛活血胶囊对强直性脊柱炎患者疾病活动和趋化因子的影响.方法:选取2021年1月-2023年1月我科住院的明确诊断为强直性脊柱炎患者60例,进行随机对照实验,对比两组的临床疗效、疼痛指数评分(VAS评分)、疾病活动量表评分(BASDAI、BASFI、BASMI、MASES)、情绪生活质量评分(HAMD、ASQoL),测定血清炎症指标(ESR、hs-CRP)、趋化因子含量(TARC、IP-10、CXCR3)和细胞因子IL-10含量.结果:两组患者治疗后症状均有所改善,运用中成药腰痛活血胶囊治疗的AS患者临床疗效优于对照组(P<0.05),疾病活动评分较对照组下降明显(P<0.05),ESR和hs-CRP含量明显降低(P<0.05),HAMD评分和ASQoL评分明显下降(P<0.05),趋化因子TARC、IP-10及受体CXCR3含量明显下降(P<0.05),细胞因子IL-10明显升高(P<0.05).Spearman 相关分析结果显示,IP-10 与 VAS 呈正相关(r=0.89,P<0.05),IL-10 水平与 BASDAI 呈负相关(r=-0.40,P<0.05).结论:腰痛活血胶囊治疗强直性脊柱炎临床应用有效,可有效降低疾病活动,改善患者情绪,提高生活质量,调节免疫.

Abstract

Objective:To study the effects of Yaotong Huoxue(腰痛活血)Capsule on disease activity and chemokines in patients with ankylosing spondylitis(AS).Methods:Sixty patients with definite diagnosis of ankylosing spondylitis who were hospitalized in our department from Jan-uary 2021 to January 2023 were selected for a randomized controlled trial.The clinical efficacy,pain visual analog scale(VAS),disease ac-tivity scores(bath ankylosing spondylitis disease activity index(BASDAI),bath ankylosing spondylitis functional index(BASFI),bath anky-losing spondylitis metrology index(BASMI),Maastricht ankylosing spondylitis enthesitis score(MASES)),emotional quality of life scores(Hamilton Rating Scale for Depression(HAMD),ankylosing spondylitis quality of life(ASQoL)),serum inflammatory indexes(erythrocyte sedimentation rate(ESR),high-sensitivity C-reactive protein(hs-CRP)),chemokine levels(thymus and activation-regulated chemokine(TARC),Interferon-γ-inducible protein 10(IP-10),CXC chemokine receptor 3(CXCR3)),and interleukin 10(IL-10)level were com-pared between the two groups.Results:After the treatment,symptoms were improved in two groups,and the clinical efficacy of AS patients treated with the Chinese patent medicine Yaotong Huoxue Capsule was better than that of the control group(P<0.05).Compared with control group,the disease activity scores were decreased significantly(P<0.01),and ESR and hs-CRP levels were increased significantly(P<0.01),with significantly decreased HAMD and ASQoL scores(P<0.01),and TARC,IP-10 and CXCR3 levels(P<0.01),and significantly increased IL-10 level(P<0.01)in the Yaotong Huoxue Capsule treatment group.Spearman's correlation analysis showed that serum IP-10 and CXCR3 levels were positively correlated with BASDAI after treatment,and IP-10 level was positively correlated with VAS(r=0.89,P<0.05).While IL-10 level was negatively correlated with BASDAI(r=-0.40,P<0.05).Conclusion:Yaotong Huoxue Capsule is effective in the clinical treatment of AS,which can effectively reduce disease activity,improve patients'mood and quality of life,and regulate the function of the immune system.

关键词

腰痛活血胶囊/柳氮磺嘧啶/强直性脊柱炎/疾病活动/趋化因子

Key words

Yaotong Huoxue(腰痛活血)Capsule/Sulfasalazine/Ankylosing spondylitis/Disease activity/Chemokines

引用本文复制引用

出版年

2024
中药药理与临床
中国药理学会 四川省中医药科学院

中药药理与临床

CSCD北大核心
影响因子:0.996
ISSN:1001-859X
段落导航相关论文